Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2009-12-09
Original SEC Filing: Click here

---

Webplus: SKBI/20091209/8-K/2_EX-99.1/000.htm SEC Original: v168568_ex99-1.htm
Skystar Bio-Pharmaceutical Acquires Exclusive Aquaculture Vaccine Technology and Provides Operational Update on Facility Development New Vaccine Technology todressmpany-Estimated $150 Million Market Opportunity Veterinary Vaccine Facility Launch Extended to First Quarter of 2010 to Accommodate New Aquaculture Vaccine Line XI’AN, CHINA, December 9 , 2009ystar Bio-Pharmaceuticalmpanyystar will manufacture its aquaculture vaccine in its new 51,000 square

---

---

Webplus: SKBI/20091209/8-K/1/000.htm SEC Original: v168568_8k.htm
FORM 8-K CURRENT REPORTte of report (Date of earliest event reported): December 9, 2009YSTAR BIO-PHARMACEUTICALMPANY Nevada 000-28153 33-0901534 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian, Shaanxi Province, P.R. China

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2009-12-09CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE